Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
90%
Crohn's Disease
68%
Biological Marker
62%
Bile Acid
54%
Nonalcoholic Fatty Liver
47%
Disease
45%
Retinol
43%
Ulcerative Colitis
35%
Bile Salt
34%
Liver Fibrosis
33%
Inflammation
32%
Liver Injury
29%
Mouse
27%
Cohort Study
25%
Disease Activity
22%
Thiol
21%
Infliximab
20%
Cigarette Smoke
20%
Collagen Type 4
19%
Fatty Liver
18%
Tumor Necrosis Factor
18%
Glycochenodeoxycholic Acid
17%
Metformin
17%
Collagen Type 1
16%
Calgranulin
16%
Fibrosis
15%
Necrosis
15%
Vedolizumab
15%
Antioxidant
15%
Farnesoid X Receptor
14%
Riboflavin
14%
Liver Disease
14%
Cytokine
14%
Remission
13%
Malignant Neoplasm
12%
Reactive Oxygen Metabolite
12%
Menadione
11%
Superoxide
11%
Matrix Metalloproteinase
10%
Short Chain Fatty Acid
10%
Transforming Growth Factor Beta
10%
Prevalence
10%
Paracetamol
10%
Enteritis
10%
Cytoprotective Agent
9%
Dextran Sulfate
9%
Disease Course
9%
Opuntia
9%
Liothyronine
9%
Liotrix
9%
Medicine and Dentistry
Inflammatory Bowel Disease
80%
Biological Marker
65%
Disease
39%
Patient with Crohn's Disease
29%
Crohn's Disease
28%
Nonalcoholic Fatty Liver
28%
Hepatocyte
27%
Extracellular Matrix
25%
Bile Acid
25%
Gut
24%
Infliximab
24%
Vedolizumab
22%
Oxidative Stress
21%
Disease Activity
21%
Collagen Type 4
20%
Hepatic Stellate Cell
20%
Ulcerative Colitis
19%
Fatty Liver
19%
Liver Fibrosis
18%
Tumor Necrosis Factor
17%
Bile Salt
17%
Collagen Type 1
16%
Treatment Response
15%
Patient with Inflammatory Bowel Disease
15%
Collagen Degradation
15%
Retinol
15%
Proteomics
14%
Gut Microbiota
12%
Enteritis
12%
Neutrophil
12%
Intestinal Epithelium
12%
Cohort Analysis
11%
In Vitro
11%
Colon
10%
Immunoregulation
10%
C Reactive Protein
9%
Intestine
9%
Short Chain Fatty Acid
9%
Dextran Sulfate
9%
Inflammasome
9%
Glycon
9%
Prevalence
9%
Cigarette Smoke
9%
Dextran Sulfate Sodium-Induced Colitis
9%
Leukocyte Elastase
9%
Protein Expression
9%
Peroxisome
9%
Epileptic Absence
9%
Hepatocellular Carcinoma
8%
Metabolism
8%
Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
38%
Oxidative Stress
20%
Fecal Calprotectin
17%
Non-alcoholic Fatty Liver Disease (NAFLD)
15%
Pichia Pastoris
14%
Endoscopic Disease Activity
14%
Intestinal Inflammation
14%
Peroxisomal
13%
Free Thiols
13%
Disease Activity
12%
Induction Therapy
12%
Vedolizumab
12%
Type I Collagen
11%
Non-inflamed
10%
Eotaxin-1
10%
Peroxisome Biogenesis
10%
Primary Rat Hepatocytes
10%
Ulcerative Colitis
10%
Hypoxia-inducible factor-1α (HIF-1α)
9%
Salt-induced
9%
Riboflavin
9%
Hansenula Polymorpha
9%
Co-immunoprecipitation (co-IP)
9%
Antibody Epitope
9%
Host-microbe Interactions
9%
Clinical Phenotype
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Peroxisome
9%
Intestinal Epithelial Cells
9%
Serum-free
8%
Crohn's Colitis
8%
High Prevalence
8%
PEX1
8%
Collagen Degradation
7%
Fibrostenotic
7%
Systemic Oxidative Stress
7%
Faecalibacterium Prausnitzii
7%
Matrix Metalloproteinases
7%
Redox Status
7%
Peroxisomal Membrane Protein
6%
Amino Acids
6%
Anti-tumor Necrosis Factor (anti-TNF)
6%
Type III Collagen
6%
Integrin
6%
Hepatocytes
6%
High-level Expression
6%
Healthy Controls
6%
Hepatic Stellate Cells
6%
Matrix Protein Import
6%
